Pharming Group N.V. ADR (PHAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 12,847 | -8,492 | -12,012 | 14,987 | 23,078 |
| Depreciation Amortization | 11,216 | 16,070 | 15,925 | 13,188 | 19,610 |
| Accounts receivable | -3,355 | -6,783 | -18,539 | 2,364 | 5,918 |
| Accounts payable and accrued liabilities | 17,820 | -2,769 | 16,228 | 11,992 | -5,193 |
| Other Working Capital | 14,079 | -10,072 | -16,961 | -387 | -4,961 |
| Other Operating Activity | 2,101 | 10,251 | -1,943 | -19,686 | -610 |
| Operating Cash Flow | $54,708 | $-1,795 | $-17,302 | $22,458 | $37,842 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 84,260 | 30,316 | -149,203 | N/A | N/A |
| PPE Investments | -749 | -790 | -1,437 | -1,376 | -10,739 |
| Net Acquisitions | -57,476 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | 2,098 | N/A | N/A | -4,589 |
| Sale Of Investment | 224 | N/A | N/A | 7,300 | N/A |
| Purchase Sale Intangibles | -6 | -6 | -27 | -601 | -5,977 |
| Other Investing Activity | -7 | -6 | 21,252 | -601 | -5,977 |
| Investing Cash Flow | $26,252 | $31,618 | $-129,388 | $5,323 | $-21,305 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 104,539 | N/A | N/A | N/A |
| Debt Repayment | N/A | -134,924 | N/A | N/A | N/A |
| Common Stock Issued | -7,876 | N/A | N/A | N/A | 4,718 |
| Other Financing Activity | 9,371 | -4,027 | -1,039 | -4,982 | -32,665 |
| Financing Cash Flow | $1,495 | $-34,412 | $-1,039 | $-4,982 | $-27,947 |
| Exchange Rate Effect | 7,907 | -2,208 | 2,128 | -7,381 | -1,825 |
| Beginning Cash Position | 54,944 | 61,741 | 207,342 | 191,924 | 205,159 |
| End Cash Position | 145,305 | 54,944 | 61,741 | 207,342 | 191,924 |
| Net Cash Flow | $90,361 | $-6,797 | $-145,601 | $15,418 | $-13,235 |
| Free Cash Flow | |||||
| Operating Cash Flow | 54,708 | -1,795 | -17,302 | 22,458 | 37,842 |
| Capital Expenditure | -749 | -790 | -1,437 | -1,376 | -10,739 |
| Free Cash Flow | 53,959 | -2,585 | -18,739 | 21,082 | 27,103 |